-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
SARS-CoV-2 nsp14-IN-2
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2816165-16-72d.gif)
| Category | SARS-CoV |
| CAS | 2816165-16-7 |
Product Information
| Synonyms | CHEMBL5198248;SARS-CoV-2 nsp14-IN-2;N-(((2R,3S,4R,5S)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)naphthalene-2-sulfonamide;Nsp14 MT inhibitor 10;SCHEMBL26668613;GLXC-26046;BDBM50601258;CS-0541715;2816165-16-7; |
| IUPAC Name | N-[[(2R,3S,4R,5S)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl]naphthalene-2-sulfonamide |
| Molecular Weight | 461.8 |
| Molecular Formula | C21H18ClF2N5O3 |
| Canonical SMILES | CN1C=NC(=N1)COC(=O)N[C@H]2CCC3=C(C=CC(=C23)F)C(=O)NC4=CC(=C(C=C4)F)Cl |
| InChI | InChI=1S/C21H21N5O5S/c22-21-16-8-7-15(26(16)24-11-23-21)20-19(28)18(27)17(31-20)10-25-32(29,30)14-6-5-12-3-1-2-4-13(12)9-14/h1-9,11,17-20,25,27-28H,10H2,(H2,22,23,24)/t17-,18-,19-,20+/m1/s1 |
| InChIKey | IYCYSBUBGPYWMH-WTGUMLROSA-N |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
